<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01733082</url>
  </required_header>
  <id_info>
    <org_study_id>ML22679</org_study_id>
    <nct_id>NCT01733082</nct_id>
  </id_info>
  <brief_title>The Mycophenolate Pregnancy Registry</brief_title>
  <official_title>The Mycophenolate Pregnancy Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Genentech, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Accord Healthcare, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sandoz</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Apotex Corporation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Novartis Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mylan Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Teva Pharmaceuticals USA</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Alkem Laboratories Ltd</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Roxane Laboratories</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vintage Pharmaceuticals, LLC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Genentech, Inc.</source>
  <brief_summary>
    <textblock>
      The Mycophenolate Pregnancy Registry is designed as a prospective, observational registry
      collecting data regarding mycophenolate exposure during pregnancy, and pregnancy outcomes,
      fetal and infant outcomes after exposure. Early and later term pregnancy outcomes will be
      solicited at selected gestational time points. Structural and functional birth defects
      identified in the perinatal period through one year of life will be collected and classified.

      This is a non-proprietary registry and is a component of a comprehensive pregnancy Risk
      Evaluation and Mitigation Strategy (REMS) plan required by the FDA for all
      mycophenolate-formulations, including CellCept, Myfortic and any generic formulations.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Maternal outcomes: Incidence of pregnancy complications</measure>
    <time_frame>approximately 8 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Fetal outcomes: Incidence of congenital disorders</measure>
    <time_frame>approximately 8 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time/duration of mycophenolate exposure</measure>
    <time_frame>approximately 8 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mycophenolate dose/regimen</measure>
    <time_frame>approximately 8 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Indications for mycophenolate use</measure>
    <time_frame>approximately 8 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Maternal medical/demographic characteristics</measure>
    <time_frame>approximately 8 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Occurrence of educational counseling on the risks of birth defects with mycophenolate therapy</measure>
    <time_frame>approximately 8 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases</condition>
  <arm_group>
    <arm_group_label>Cohort</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnancy and reported exposure to mycophenolate during pregnancy or within 6 weeks of
        discontinuing treatment
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnancy and reported maternal exposure to mycophenolate during pregnancy or within 6
             weeks of discontinuing treatment

        Exclusion Criteria:

          -  Pregnancies for which there is paternal exposure only

          -  Pregnancies occurring outside the U.S.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>Genentech, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Reference Study ID Number: ML22679 www.roche.com/about_roche/roche_worldwide.htm</last_name>
    <phone>888-662-6728 (U.S. and Canada)</phone>
    <email>global.rochegenentechtrials@roche.com</email>
  </overall_contact>
  <location>
    <facility>
      <address>
        <city>Cambridge</city>
        <state>Massachusetts</state>
        <zip>02139</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 20, 2012</study_first_submitted>
  <study_first_submitted_qc>November 23, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 26, 2012</study_first_posted>
  <last_update_submitted>November 1, 2016</last_update_submitted>
  <last_update_submitted_qc>November 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 2, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Autoimmune Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mycophenolic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

